Monomax Xl (Isosorbide Mononitrate)

Isosorbide Mononitrate is used within the nitrate anti‑anginal drug class to manage coronary artery disease‑related chest pain.

• Prophylaxis of angina pectoris: reduces the frequency of angina attacks during daily activities.
• Treatment of chronic stable angina: improves exercise tolerance and decreases symptom burden.
• Prevention of exertional angina: helps maintain functional capacity by limiting myocardial oxygen demand.

• Isosorbide Mononitrate is absorbed and metabolized to nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting increase in cyclic GMP leads to relaxation of arterial and venous vessels, producing vasodilation, reduced preload and afterload, and consequently lower myocardial oxygen consumption.

Isosorbide Mononitrate may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects

• Headache: throbbing pain often occurring shortly after dosing.
• Dizziness or light‑headedness: related to blood pressure reduction.
• Flushing: warm sensation and reddening of the skin.
• Nausea: mild gastrointestinal upset.
• Palpitations: awareness of heartbeat acceleration.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Syncope: sudden loss of consciousness.
• Myocardial infarction: rare but possible in susceptible patients.
• Allergic reactions: rash, itching, or swelling.
• Stevens‑Johnson syndrome: severe skin reaction.
• Life‑threatening bradycardia: markedly slow heart rate.

Before prescribing Isosorbide Mononitrate, clinicians should evaluate patient‑specific risk factors and monitor therapy closely.

• Assess cardiovascular status: check baseline blood pressure and heart rate.
• Review concomitant nitrate use: avoid additive vasodilatory effects.
• Evaluate hepatic or renal impairment: adjust monitoring as needed.
• Counsel on orthostatic changes: advise patients to rise slowly from sitting or lying positions.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Isosorbide Mononitrate can interact with several drug classes, influencing its safety profile.

Major Interactions (Avoid)

• Other nitrates (e.g., nitroglycerin): risk of profound hypotension.
• Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause severe blood pressure drops.
• Antihypertensive agents (e.g., ACE inhibitors, ARBs): additive blood‑pressure‑lowering effect.

Moderate Interactions (Monitor Closely)

• Alcohol: can enhance hypotensive response.
• Diuretics: may increase risk of volume depletion and low blood pressure.
• Beta‑blockers: monitor for excessive heart‑rate reduction and hypotension.